-
-
-
-
-
-
-
Caris Life Sciences launches AI-powered breast cancer recurrence test
-
-
-
-
-
-
-
Caris Life Sciences Inc (CAI) PT Lowered to $22 at Canaccord
-
-
-
-
-
-
-
Caris Life Sciences reports 94% revenue growth for 2025
-
-
-
-
-
-
-
Caris Life Sciences Inc (CAI) PT Raised to $40 at Evercore ISI
-
-
-
-
-
-
-
TD Cowen Starts Caris Life Sciences Inc (CAI) at Buy
-
-
-
-
-
-
-
Caris Life Sciences (CAI) Opens at $27, IPO Priced at $21
-
-
-
-
428,613 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

